APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nifedipine Industry Growth and Trends Forecast to 2032

22 December 2025107 pages

Choose your research edition.

Industry ResearchNifedipine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nifedipine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nifedipine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nifedipine include Actavis, Bayer, Honglin Pharmaceutical, Huanghai, Pfizer, Lifeon Pharmaceutical, Teva, Simcere and Shyndec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nifedipine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nifedipine market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nifedipine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nifedipine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nifedipine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nifedipine Market by Company

Actavis

Bayer

Honglin Pharmaceutical

Huanghai

Pfizer

Lifeon Pharmaceutical

Teva

Simcere

Shyndec

Yabao

ApicHope

EASEHEAL Pharmaceutical

Nifedipine Segment by Type

Nifedipine Controlled Release Tablets

Nifedipine Extended Action Tablets

Nifedipine Segment by Application

Hypertension

Heart Disease

Other

Nifedipine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nifedipine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nifedipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nifedipine Controlled Release Tablets Table 2. Major Company of Nifedipine Extended Action Tablets Table 3. Global Nifedipine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nifedipine Sales by Type (2021-2026) & (tons) Table 5. Global Nifedipine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nifedipine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nifedipine Sales Market Share in Value by Type (2021-2026) Table 8. Global Nifedipine Price by Type (2021-2026) & (US$/kg) Table 9. Global Nifedipine Sales by Type (2027-2032) & (tons) Table 10. Global Nifedipine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nifedipine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nifedipine Sales Market Share in Value by Type (2027-2032) Table 13. Global Nifedipine Price by Type (2027-2032) & (US$/kg) Table 14. North America Nifedipine Sales by Type (2021-2026) & (tons) Table 15. North America Nifedipine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nifedipine Sales by Type (2021-2026) & (tons) Table 17. Europe Nifedipine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nifedipine Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Nifedipine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nifedipine Sales by Type (2021-2026) & (tons) Table 21. Latin America Nifedipine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nifedipine Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Nifedipine Sales by Type (2021-2026) & (US$ Million) Table 24. Nifedipine Industry Trends Table 25. Nifedipine Industry Drivers Table 26. Nifedipine Industry Opportunities and Challenges Table 27. Nifedipine Industry Restraints Table 28. Global Nifedipine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nifedipine Revenue Market Share by Company (2021-2026) Table 30. Global Nifedipine Sales by Company (2021-2026) & (tons) Table 31. Global Nifedipine Sales Share by Company (2021-2026) Table 32. Global Nifedipine Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Nifedipine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nifedipine Major Company Production Sites and Headquarters Table 35. Global Nifedipine Company, Product Type & Application Table 36. Global Nifedipine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nifedipine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nifedipine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nifedipine Sales by Region (2021-2026) & (tons) Table 41. Global Nifedipine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nifedipine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nifedipine Sales Market Share in Value by Region (2021-2026) Table 44. Global Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Nifedipine Sales by Region (2027-2032) & (tons) Table 46. Global Nifedipine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nifedipine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nifedipine Sales Market Share in Value by Region (2027-2032) Table 49. Global Nifedipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Nifedipine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nifedipine Sales by Application (2021-2026) & (tons) Table 52. Global Nifedipine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nifedipine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nifedipine Sales Market Share in Value by Application (2021-2026) Table 55. Global Nifedipine Price by Application (2021-2026) & (US$/kg) Table 56. Global Nifedipine Sales by Application (2027-2032) & (tons) Table 57. Global Nifedipine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nifedipine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nifedipine Sales Market Share in Value by Application (2027-2032) Table 60. Global Nifedipine Price by Application (2027-2032) & (US$/kg) Table 61. North America Nifedipine Sales by Application (2021-2026) & (tons) Table 62. North America Nifedipine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nifedipine Sales by Application (2021-2026) & (tons) Table 64. Europe Nifedipine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nifedipine Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Nifedipine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nifedipine Sales by Application (2021-2026) & (tons) Table 68. Latin America Nifedipine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nifedipine Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Nifedipine Sales by Application (2021-2026) & (US$ Million) Table 71. Actavis Company Information Table 72. Actavis Business Overview Table 73. Actavis Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Actavis Nifedipine Product Portfolio Table 75. Actavis Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Bayer Nifedipine Product Portfolio Table 80. Bayer Recent Development Table 81. Honglin Pharmaceutical Company Information Table 82. Honglin Pharmaceutical Business Overview Table 83. Honglin Pharmaceutical Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Honglin Pharmaceutical Nifedipine Product Portfolio Table 85. Honglin Pharmaceutical Recent Development Table 86. Huanghai Company Information Table 87. Huanghai Business Overview Table 88. Huanghai Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Huanghai Nifedipine Product Portfolio Table 90. Huanghai Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Pfizer Nifedipine Product Portfolio Table 95. Pfizer Recent Development Table 96. Lifeon Pharmaceutical Company Information Table 97. Lifeon Pharmaceutical Business Overview Table 98. Lifeon Pharmaceutical Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Lifeon Pharmaceutical Nifedipine Product Portfolio Table 100. Lifeon Pharmaceutical Recent Development Table 101. Teva Company Information Table 102. Teva Business Overview Table 103. Teva Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Teva Nifedipine Product Portfolio Table 105. Teva Recent Development Table 106. Simcere Company Information Table 107. Simcere Business Overview Table 108. Simcere Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Simcere Nifedipine Product Portfolio Table 110. Simcere Recent Development Table 111. Shyndec Company Information Table 112. Shyndec Business Overview Table 113. Shyndec Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. Shyndec Nifedipine Product Portfolio Table 115. Shyndec Recent Development Table 116. Yabao Company Information Table 117. Yabao Business Overview Table 118. Yabao Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 119. Yabao Nifedipine Product Portfolio Table 120. Yabao Recent Development Table 121. ApicHope Company Information Table 122. ApicHope Business Overview Table 123. ApicHope Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 124. ApicHope Nifedipine Product Portfolio Table 125. ApicHope Recent Development Table 126. EASEHEAL Pharmaceutical Company Information Table 127. EASEHEAL Pharmaceutical Business Overview Table 128. EASEHEAL Pharmaceutical Nifedipine Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 129. EASEHEAL Pharmaceutical Nifedipine Product Portfolio Table 130. EASEHEAL Pharmaceutical Recent Development Table 131. North America Nifedipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 132. North America Nifedipine Sales by Country (2021-2026) & (tons) Table 133. North America Nifedipine Sales Market Share by Country (2021-2026) Table 134. North America Nifedipine Sales Forecast by Country (2027-2032) & (tons) Table 135. North America Nifedipine Sales Market Share Forecast by Country (2027-2032) Table 136. North America Nifedipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Nifedipine Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Nifedipine Market Share by Country (2021-2026) Table 139. North America Nifedipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Nifedipine Market Share Forecast by Country (2027-2032) Table 141. Europe Nifedipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 142. Europe Nifedipine Sales by Country (2021-2026) & (tons) Table 143. Europe Nifedipine Sales Market Share by Country (2021-2026) Table 144. Europe Nifedipine Sales Forecast by Country (2027-2032) & (tons) Table 145. Europe Nifedipine Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Nifedipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Nifedipine Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Nifedipine Market Share by Country (2021-2026) Table 149. Europe Nifedipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Nifedipine Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Nifedipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Nifedipine Sales by Country (2021-2026) & (tons) Table 153. Asia-Pacific Nifedipine Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Nifedipine Sales Forecast by Country (2027-2032) & (tons) Table 155. Asia-Pacific Nifedipine Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Nifedipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Nifedipine Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Nifedipine Market Share by Country (2021-2026) Table 159. Asia-Pacific Nifedipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Nifedipine Market Share Forecast by Country (2027-2032) Table 161. Latin America Nifedipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 162. Latin America Nifedipine Sales by Country (2021-2026) & (tons) Table 163. Latin America Nifedipine Sales Market Share by Country (2021-2026) Table 164. Latin America Nifedipine Sales Forecast by Country (2027-2032) & (tons) Table 165. Latin America Nifedipine Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Nifedipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Nifedipine Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Nifedipine Market Share by Country (2021-2026) Table 169. Latin America Nifedipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Nifedipine Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Nifedipine Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Nifedipine Sales by Country (2021-2026) & (tons) Table 173. Middle East and Africa Nifedipine Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Nifedipine Sales Forecast by Country (2027-2032) & (tons) Table 175. Middle East and Africa Nifedipine Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Nifedipine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Nifedipine Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Nifedipine Market Share by Country (2021-2026) Table 179. Middle East and Africa Nifedipine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Nifedipine Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Nifedipine Distributors List Table 184. Nifedipine Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Nifedipine Image Figure 2. Global Nifedipine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Market Size (2021-2032) & (US$ Million) Figure 4. Global Nifedipine Sales (2021-2032) & (tons) Figure 5. Nifedipine Controlled Release Tablets Image Figure 6. Global Nifedipine Controlled Release Tablets Sales YoY Growth (2021-2032) & (tons) Figure 7. Nifedipine Extended Action Tablets Image Figure 8. Global Nifedipine Extended Action Tablets Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Nifedipine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nifedipine Market Share by Type 2025 VS 2032 Figure 11. North America Nifedipine Sales Market Share in Volume by Type in 2025 Figure 12. North America Nifedipine Sales Market Share in Value by Type in 2025 Figure 13. Europe Nifedipine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nifedipine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nifedipine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nifedipine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nifedipine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nifedipine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nifedipine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nifedipine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nifedipine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hypertension Image Figure 24. Global Hypertension Sales YoY Growth (2021-2032) & (tons) Figure 25. Heart Disease Image Figure 26. Global Heart Disease Sales YoY Growth (2021-2032) & (tons) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (tons) Figure 29. Global Nifedipine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Nifedipine Market Share by Application 2025 VS 2032 Figure 31. North America Nifedipine Sales Market Share in Volume by Application in 2025 Figure 32. North America Nifedipine Sales Market Share in Value by Application in 2025 Figure 33. Europe Nifedipine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Nifedipine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Nifedipine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Nifedipine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Nifedipine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Nifedipine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Nifedipine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Nifedipine Sales Market Share in Value by Application in 2025 Figure 41. North America Nifedipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 42. North America Nifedipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Nifedipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Nifedipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nifedipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. Europe Nifedipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nifedipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nifedipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nifedipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Asia-Pacific Nifedipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nifedipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Nifedipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nifedipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Latin America Nifedipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nifedipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Nifedipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nifedipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Middle East and Africa Nifedipine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nifedipine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Nifedipine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Nifedipine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Nifedipine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Nifedipine Controlled Release Tablets
  • Nifedipine Extended Action Tablets
Applications
  • Hypertension
  • Heart Disease
  • Other
Companies covered
  • Actavis
  • Bayer
  • Honglin Pharmaceutical
  • Huanghai
  • Pfizer
  • Lifeon Pharmaceutical
  • Teva
  • Simcere
  • Shyndec
  • Yabao
  • ApicHope
  • EASEHEAL Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nifedipine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nifedipine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nifedipine Market by Type
  6. 1.3.1 Nifedipine Controlled Release Tablets
  7. 1.3.2 Nifedipine Extended Action Tablets
  8. 1.4 Global Nifedipine Market Size by Type
  9. 1.4.1 Global Nifedipine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nifedipine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nifedipine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nifedipine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nifedipine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nifedipine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nifedipine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nifedipine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nifedipine Industry Trends
  2. 2.2 Nifedipine Industry Drivers
  3. 2.3 Nifedipine Industry Opportunities and Challenges
  4. 2.4 Nifedipine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nifedipine Revenue (2021-2026)
  2. 3.2 Global Top Players by Nifedipine Sales (2021-2026)
  3. 3.3 Global Top Players by Nifedipine Price (2021-2026)
  4. 3.4 Global Nifedipine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nifedipine Major Company Production Sites & Headquarters
  6. 3.6 Global Nifedipine Company, Product Type & Application
  7. 3.7 Global Nifedipine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nifedipine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nifedipine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nifedipine Tier 1, Tier 2, and Tier 3
4 Nifedipine Regional Status and Outlook
  1. 4.1 Global Nifedipine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nifedipine Historic Market Size by Region
  3. 4.2.1 Global Nifedipine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nifedipine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nifedipine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nifedipine Forecasted Market Size by Region
  7. 4.3.1 Global Nifedipine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nifedipine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nifedipine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nifedipine by Application
  1. 5.1 Nifedipine Market by Application
  2. 5.1.1 Hypertension
  3. 5.1.2 Heart Disease
  4. 5.1.3 Other
  5. 5.2 Global Nifedipine Market Size by Application
  6. 5.2.1 Global Nifedipine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nifedipine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nifedipine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nifedipine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nifedipine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nifedipine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nifedipine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nifedipine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actavis
  2. 6.1.1 Actavis Company Information
  3. 6.1.2 Actavis Business Overview
  4. 6.1.3 Actavis Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actavis Nifedipine Product Portfolio
  6. 6.1.5 Actavis Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Nifedipine Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Honglin Pharmaceutical
  14. 6.3.1 Honglin Pharmaceutical Company Information
  15. 6.3.2 Honglin Pharmaceutical Business Overview
  16. 6.3.3 Honglin Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Honglin Pharmaceutical Nifedipine Product Portfolio
  18. 6.3.5 Honglin Pharmaceutical Recent Developments
  19. 6.4 Huanghai
  20. 6.4.1 Huanghai Company Information
  21. 6.4.2 Huanghai Business Overview
  22. 6.4.3 Huanghai Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Huanghai Nifedipine Product Portfolio
  24. 6.4.5 Huanghai Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Nifedipine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Lifeon Pharmaceutical
  32. 6.6.1 Lifeon Pharmaceutical Company Information
  33. 6.6.2 Lifeon Pharmaceutical Business Overview
  34. 6.6.3 Lifeon Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lifeon Pharmaceutical Nifedipine Product Portfolio
  36. 6.6.5 Lifeon Pharmaceutical Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Nifedipine Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Simcere
  44. 6.8.1 Simcere Company Information
  45. 6.8.2 Simcere Business Overview
  46. 6.8.3 Simcere Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Simcere Nifedipine Product Portfolio
  48. 6.8.5 Simcere Recent Developments
  49. 6.9 Shyndec
  50. 6.9.1 Shyndec Company Information
  51. 6.9.2 Shyndec Business Overview
  52. 6.9.3 Shyndec Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shyndec Nifedipine Product Portfolio
  54. 6.9.5 Shyndec Recent Developments
  55. 6.10 Yabao
  56. 6.10.1 Yabao Company Information
  57. 6.10.2 Yabao Business Overview
  58. 6.10.3 Yabao Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Yabao Nifedipine Product Portfolio
  60. 6.10.5 Yabao Recent Developments
  61. 6.11 ApicHope
  62. 6.11.1 ApicHope Company Information
  63. 6.11.2 ApicHope Business Overview
  64. 6.11.3 ApicHope Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ApicHope Nifedipine Product Portfolio
  66. 6.11.5 ApicHope Recent Developments
  67. 6.12 EASEHEAL Pharmaceutical
  68. 6.12.1 EASEHEAL Pharmaceutical Company Information
  69. 6.12.2 EASEHEAL Pharmaceutical Business Overview
  70. 6.12.3 EASEHEAL Pharmaceutical Nifedipine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 EASEHEAL Pharmaceutical Nifedipine Product Portfolio
  72. 6.12.5 EASEHEAL Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Nifedipine Sales by Country
  2. 7.1.1 North America Nifedipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nifedipine Sales by Country (2021-2026)
  4. 7.1.3 North America Nifedipine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nifedipine Market Size by Country
  6. 7.2.1 North America Nifedipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nifedipine Market Size by Country (2021-2026)
  8. 7.2.3 North America Nifedipine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nifedipine Sales by Country
  2. 8.1.1 Europe Nifedipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nifedipine Sales by Country (2021-2026)
  4. 8.1.3 Europe Nifedipine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nifedipine Market Size by Country
  6. 8.2.1 Europe Nifedipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nifedipine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nifedipine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nifedipine Sales by Country
  2. 9.1.1 Asia-Pacific Nifedipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nifedipine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nifedipine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nifedipine Market Size by Country
  6. 9.2.1 Asia-Pacific Nifedipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nifedipine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nifedipine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nifedipine Sales by Country
  2. 10.1.1 South America Nifedipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nifedipine Sales by Country (2021-2026)
  4. 10.1.3 South America Nifedipine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nifedipine Market Size by Country
  6. 10.2.1 South America Nifedipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nifedipine Market Size by Country (2021-2026)
  8. 10.2.3 South America Nifedipine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nifedipine Sales by Country
  2. 11.1.1 Middle East and Africa Nifedipine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nifedipine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nifedipine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nifedipine Market Size by Country
  6. 11.2.1 Middle East and Africa Nifedipine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nifedipine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nifedipine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nifedipine Value Chain Analysis
  2. 12.1.1 Nifedipine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nifedipine Production Mode & Process
  7. 12.2 Nifedipine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nifedipine Distributors
  10. 12.2.3 Nifedipine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst